Deals
Danaher Shelves Its Takeover Pursuit of Catalent
This article is for subscribers only.
Life-sciences company Danaher Corp. has stopped pursuing Catalent Inc. after expressing interest in buying the contract manufacturer, according to people familiar with the matter.
Danaher is no longer considering a takeover offer, said the people, who asked to not be identified because the matter isn’t public. Danaher had made overtures to Catalent valuing it at a significant premium, Bloomberg News reported in February.